89R4068 CJD-D     By: Moody H.B. No. 3242       A BILL TO BE ENTITLED   AN ACT   relating to the criminal and licensing consequences of certain   offenses relating to the possession of marihuana, certain   tetrahydrocannabinols, certain synthetic cannabinoids, and drug   paraphernalia; imposing a fee.          BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:          SECTION 1.  Article 14.06, Code of Criminal Procedure, is   amended by adding Subsections (b-1) and (b-2) and amending   Subsection (d) to read as follows:          (b-1)  A peace officer who is charging a person with   committing an offense under Section 481.1161(b)(1), 481.121(b)(1),   or 481.125(a), Health and Safety Code, may not arrest the person and   shall issue the person a citation as provided by Subsection (b).          (b-2)  Subsection (b-1) does not apply to an officer making   an arrest for an offense other than an offense under Section   481.1161(b)(1), 481.121(b)(1), or 481.125(a), Health and Safety   Code.          (d)  Subsection (c) applies only to a person charged with   committing an offense under:                (1)  Section 481.121, Health and Safety Code, if the   offense is punishable under Subsection (b)(1-a) [(b)(1)] or (2) of   that section;                (1-a)  Section 481.1161, Health and Safety Code, if the   offense is punishable under Subsection (b)(1-a) [(b)(1)] or (2) of   that section;                (2)  Section 28.03, Penal Code, if the offense is   punishable under Subsection (b)(2) of that section;                (3)  Section 28.08, Penal Code, if the offense is   punishable under Subsection (b)(2) or (3) of that section;                (4)  Section 31.03, Penal Code, if the offense is   punishable under Subsection (e)(2)(A) of that section;                (5)  Section 31.04, Penal Code, if the offense is   punishable under Subsection (e)(2) of that section;                (5-a)  Section 37.10, Penal Code, if the offense is for   tampering with a temporary tag issued under Chapter 502 or 503,   Transportation Code;                (6)  Section 38.114, Penal Code, if the offense is   punishable as a Class B misdemeanor; or                (7)  Section 521.457, Transportation Code.          SECTION 2.  Article 45A.302, Code of Criminal Procedure, is   amended by adding Subsection (a-1) to read as follows:          (a-1)  Unless the defendant has previously received a   deferral of disposition for an offense under Section   481.1161(b)(1), 481.121(b)(1), or 481.125(a), Health and Safety   Code, committed within the 12-month period preceding the date of   the commission of the instant offense, on plea of guilty or nolo   contendere for either offense, the judge shall defer further   proceedings without entering an adjudication of guilt and place the   defendant on deferred disposition under the provisions of this   article.          SECTION 3.  Article 45A.305, Code of Criminal Procedure, is   amended by adding Subsection (a-1) to read as follows:          (a-1)  A court that dismisses a complaint under Subsection   (a) for a person charged with an offense under Section   481.1161(b)(1), 481.121(b)(1), or 481.125(a), Health and Safety   Code, shall notify the defendant in writing of the person's   expunction rights under Article 45A.501 and provide the person with   a copy of that article.          SECTION 4.  Chapter 45A, Code of Criminal Procedure, is   amended by adding Subchapter K to read as follows:   SUBCHAPTER K. EXPUNCTIONS          Art. 45A.501.  EXPUNCTION OF CERTAIN RECORDS. (a) This   article applies only to a person charged with an offense under   Section 481.1161(b)(1), 481.121(b)(1), or 481.125(a), Health and   Safety Code.          (b)  Records of a person relating to a complaint may be   expunged under this article if:                (1)  the complaint was dismissed under Article 45A.305   or 45A.401 or other law and:                      (A)  at least 180 days have elapsed from the date   of the dismissal; or                      (B)  at least one year has elapsed from the date of   the citation; or                (2)  the person was acquitted of the offense.          (c)  The person must make a written request to have the   records expunged. The request must be under oath.          (d)  The court shall order all complaints, verdicts,   sentences, and prosecutorial and law enforcement records and any   other documents relating to the offense expunged from the person's   record if the court finds that the person satisfies the   requirements of this article.          (e)  The justice or municipal court shall require a person   who requests expungement under this article to pay a fee in the   amount of $30 to defray the cost of notifying state agencies of   orders of expungement under this article.          (f)  The procedures for expunction provided under this   article are separate and distinct from the expunction procedures   under Chapter 55A.          SECTION 5.  Section 411.0728(a), Government Code, is amended   to read as follows:          (a)  This section applies only to a person:                (1)  who is convicted of or placed on deferred   adjudication community supervision for an offense under:                      (A)  Section 481.1161, Health and Safety Code, if   the offense is punishable under Subsection (b)(1-a);                      (B)  Section 481.120, Health and Safety Code, if   the offense is punishable under Subsection (b)(1);                      (C) [(B)]  Section 481.121, Health and Safety   Code, if the offense is punishable under Subsection (b)(1-a)    [(b)(1)];                      (D) [(C)]  Section 31.03, Penal Code, if the   offense is punishable under Subsection (e)(1) or (2); or                      (E) [(D)]  Section 43.02, Penal Code; and                (2)  who, if requested by the applicable law   enforcement agency or prosecuting attorney to provide assistance in   the investigation or prosecution of an offense under Section   20A.02, 20A.03, or 43.05, Penal Code, or a federal offense   containing elements that are substantially similar to the elements   of an offense under any of those sections:                      (A)  provided assistance in the investigation or   prosecution of the offense; or                      (B)  did not provide assistance in the   investigation or prosecution of the offense due to the person's age   or a physical or mental disability resulting from being a victim of   an offense described by this subdivision.          SECTION 6.  Sections 481.002(5) and (6), Health and Safety   Code, are amended to read as follows:                (5)  "Controlled substance" means a substance,   including a drug, an adulterant, and a dilutant, listed in   Schedules I through V or Penalty Group 1, 1-A, 1-B, 2, 2-A, 2-B, 3,   or 4. The term includes the aggregate weight of any mixture,   solution, or other substance containing a controlled substance.   The term does not include hemp, as defined by Section 121.001,   Agriculture Code, or the tetrahydrocannabinols in hemp.                (6)  "Controlled substance analogue" means:                      (A)  a substance with a chemical structure   substantially similar to the chemical structure of a controlled   substance in Schedule I or II or Penalty Group 1, 1-A, 1-B, 2, [or]   2-A, or 2-B; or                      (B)  a substance specifically designed to produce   an effect substantially similar to, or greater than, the effect of a   controlled substance in Schedule I or II or Penalty Group 1, 1-A,   1-B, 2, [or] 2-A, or 2-B.          SECTION 7.  Section 481.103(a), Health and Safety Code, is   amended to read as follows:          (a)  Penalty Group 2 consists of:                (1)  any quantity of the following hallucinogenic   substances, their salts, isomers, and salts of isomers, unless   specifically excepted, if the existence of these salts, isomers,   and salts of isomers is possible within the specific chemical   designation:                      5-(2-aminopropyl)benzofuran (5-APB);                      6-(2-aminopropyl)benzofuran (6-APB);                      5-(2-aminopropyl)-2,3-dihydrobenzofuran   (5-APDB);                      6-(2-aminopropyl)-2,3-dihydrobenzofuran   (6-APDB);                      5-(2-aminopropyl)indole (5-IT,5-API);                      6-(2-aminopropyl)indole (6-IT,6-API);                      1-(benzofuran-5-yl)-N-methylpropan-2-amine   (5-MAPB);                      1-(benzofuran-6-yl)-N-methylpropan-2-amine   (6-MAPB);                      Benzothiophenylcyclohexylpiperidine (BTCP);                      8-bromo-alpha-methyl-benzo[1,2-b:4,5-b']difuran-   4-ethanamine (trade or other name: Bromo-DragonFLY);                      Desoxypipradrol (2-benzhydrylpiperidine);                      2, 5-dimethoxyamphetamine (some trade or other   names:  2, 5-dimethoxy-alpha-methylphenethylamine; 2, 5-DMA);                      Diphenylprolinol (diphenyl(pyrrolidin-2-yl)   methanol, D2PM);                      Dronabinol (synthetic) in sesame oil and   encapsulated in a soft gelatin capsule in a U.S. Food and Drug   Administration approved drug product (some trade or other names for   Dronabinol:  (a6aR-trans)-6a,7,8,10a-tetrahydro- 6,6, 9-   trimethyl-3-pentyl-6H- dibenzo [b,d]pyran-1-ol or (-)-delta-9-   (trans)- tetrahydrocannabinol);                      Ethylamine Analog of Phencyclidine (some trade or   other names:  N-ethyl-1-phenylcyclohexylamine, (1-   phenylcyclohexyl) ethylamine, N-(1-phenylcyclohexyl) ethylamine,   cyclohexamine, PCE);                      2-ethylamino-2-(3-methoxyphenyl)cyclohexanone   (trade or other name: methoxetamine);                      Ibogaine (some trade or other names:  7-Ethyl-6,   6, beta 7, 8, 9, 10, 12, 13-octahydro-2-methoxy-6, 9-methano-5H-   pyrido [1', 2':1, 2] azepino [5, 4-b] indole; tabernanthe iboga.);                      5-iodo-2-aminoindane (5-IAI);                      Mescaline;                      5-methoxy-3, 4-methylenedioxy amphetamine;                      4-methoxyamphetamine (some trade or other   names:  4-methoxy-alpha-methylphenethylamine;   paramethoxyamphetamine; PMA);                      4-methoxymethamphetamine (PMMA);                      2-(2-methoxyphenyl)-2-(methylamino)cyclohexanone   (some trade and other names: 2-MeO-ketamine; methoxyketamine);                      1-methyl- 4-phenyl-4-propionoxypiperidine (MPPP,   PPMP);                      4-methyl-2, 5-dimethoxyamphetamine (some trade   and other names:  4-methyl-2, 5-dimethoxy-alpha-   methylphenethylamine; "DOM"; "STP");                      3,4-methylenedioxy methamphetamine (MDMA, MDM);                      3,4-methylenedioxy amphetamine;                      3,4-methylenedioxy N-ethylamphetamine (Also   known as N-ethyl MDA);                      5,6-methylenedioxy-2-aminoindane (MDAI);                      Nabilone (Another name for nabilone:  (+)-trans-   3-(1,1-dimethylheptyl)- 6,6a, 7,8,10,10a-hexahydro-1-hydroxy- 6,   6-dimethyl-9H-dibenzo[b,d] pyran-9-one;                      N-benzylpiperazine (some trade or other   names:  BZP; 1-benzylpiperazine);                      N-ethyl-3-piperidyl benzilate;                      N-hydroxy-3,4-methylenedioxyamphetamine (Also   known as N-hydroxy MDA);                      4-methylaminorex;                      N-methyl-3-piperidyl benzilate;                      Parahexyl (some trade or other names:  3-Hexyl-1-   hydroxy-7, 8, 9, 10-tetrahydro-6, 6, 9-trimethyl-6H-dibenzo [b, d]   pyran; Synhexyl);                      1-Phenylcyclohexylamine;                      1-Piperidinocyclohexanecarbonitrile (PCC);                      Pyrrolidine Analog of Phencyclidine (some trade   or other names:  1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP);                      [Tetrahydrocannabinols, other than marihuana, and   synthetic equivalents of the substances contained in the plant, or   in the resinous extractives of Cannabis, or synthetic substances,   derivatives, and their isomers with similar chemical structure and   pharmacological activity such as:                            [delta-1 cis or trans tetrahydrocannabinol,   and their optical isomers;                            [delta-6 cis or trans tetrahydrocannabinol,   and their optical isomers;                            [delta-3, 4 cis or trans   tetrahydrocannabinol, and its optical isomers; or                            [compounds of these structures, regardless   of numerical designation of atomic positions, since nomenclature of   these substances is not internationally standardized;]                      Thiophene Analog of Phencyclidine (some trade or   other names:  1-[1-(2-thienyl) cyclohexyl] piperidine; 2-Thienyl   Analog of Phencyclidine; TPCP, TCP);                      1-pyrrolidine (some trade or other name:  TCPy);                      1-(3-trifluoromethylphenyl)piperazine (trade or   other name:  TFMPP); and                      3,4,5-trimethoxy amphetamine;                (2)  Phenylacetone (some trade or other   names:  Phenyl-2-propanone; P2P, Benzymethyl ketone, methyl benzyl   ketone);                (3)  unless specifically excepted or unless listed in   another Penalty Group, a material, compound, mixture, or   preparation that contains any quantity of the following substances   having a potential for abuse associated with a depressant or   stimulant effect on the central nervous system:                      Aminorex (some trade or other   names:  aminoxaphen; 2-amino-5-phenyl-2-oxazoline; 4,5-dihydro-5-   phenyl-2-oxazolamine);                      Amphetamine, its salts, optical isomers, and   salts of optical isomers;                      Cathinone (some trade or other names:  2-amino-1-   phenyl-1-propanone, alpha-aminopropiophenone, 2-   aminopropiophenone);                      Etaqualone and its salts;                      Etorphine Hydrochloride;                      Fenethylline and its salts;                      Lisdexamfetamine, including its salts, isomers,   and salts of isomers;                      Mecloqualone and its salts;                      Methaqualone and its salts;                      Methcathinone (some trade or other names:  2-   methylamino-propiophenone; alpha-(methylamino)propriophenone;   2-(methylamino)-1-phenylpropan-1-one; alpha-N-   methylaminopropriophenone; monomethylpropion; ephedrone, N-   methylcathinone; methylcathinone; AL-464; AL-422; AL-463; and UR   1431);                      N-Ethylamphetamine, its salts, optical isomers,   and salts of optical isomers; and                      N,N-dimethylamphetamine (some trade or other   names: N,N,alpha-trimethylbenzeneethanamine;   N,N,alpha-trimethylphenethylamine), its salts, optical isomers,   and salts of optical isomers;                (4)  any compound structurally derived from   2-aminopropanal by substitution at the 1-position with any   monocyclic or fused-polycyclic ring system, including:                      (A)  compounds further modified by:                            (i)  substitution in the ring system to any   extent (including alkyl, alkoxy, alkylenedioxy, haloalkyl, or   halide substituents), whether or not further substituted in the   ring system by other substituents;                            (ii)  substitution at the 3-position with an   alkyl substituent; or                            (iii)  substitution at the 2-amino nitrogen   atom with alkyl, benzyl, dialkyl, or methoxybenzyl groups, or   inclusion of the 2-amino nitrogen atom in a cyclic structure; and                      (B)  by example, compounds such as:                            4-Methylmethcathinone (Also known as   Mephedrone);                            3,4-Dimethylmethcathinone (Also known as   3,4-DMMC);                            3-Fluoromethcathinone (Also known as 3-FMC);                            4-Fluoromethcathinone (Also known as   Flephedrone);                            3,4-Methylenedioxy-N-methylcathinone (Also   known as Methylone);                            3,4-Methylenedioxypyrovalerone (Also known   as MDPV);                            alpha-Pyrrolidinopentiophenone (Also known   as alpha-PVP);                            Naphthylpyrovalerone  (Also known as   Naphyrone);                            alpha-Methylamino-valerophenone (Also known   as Pentedrone);                            beta-Keto-N-methylbenzodioxolylpropylamine   (Also known as Butylone);                            beta-Keto-N-methylbenzodioxolylpentanamine   (Also known as Pentylone);                            beta-Keto-Ethylbenzodioxolylbutanamine   (Also known as Eutylone); and                            3,4-methylenedioxy-N-ethylcathinone (Also   known as Ethylone);                (5)  any compound structurally derived from tryptamine   (3-(2-aminoethyl)indole) or a ring-hydroxy tryptamine:                      (A)  by modification in any of the following ways:                            (i)  by substitution at the amine nitrogen   atom of the sidechain to any extent with alkyl or alkenyl groups or   by inclusion of the amine nitrogen atom of the side chain (and no   other atoms of the side chain) in a cyclic structure;                            (ii)  by substitution at the carbon atom   adjacent to the nitrogen atom of the side chain (alpha-position)   with an alkyl or alkenyl group;                            (iii)  by substitution in the 6-membered   ring to any extent with alkyl, alkoxy, haloalkyl, thioaklyl,   alkylenedioxy, or halide substituents; or                            (iv)  by substitution at the 2-position of   the tryptamine ring system with an alkyl substituent; and                      (B)  including:                            (i)  ethers and esters of the controlled   substances listed in this subdivision; and                            (ii)  by example, compounds such as:                                  alpha-ethyltryptamine;                                  alpha-methyltryptamine;                                  Bufotenine (some trade and other names:   3-(beta-Dimethylaminoethyl)-5-hydroxyindole;   3-(2-dimethylaminoethyl)- 5- indolol; N, N-dimethylserotonin;   5-hydroxy-N, N- dimethyltryptamine; mappine);                                  Diethyltryptamine (some trade and   other names: N, N-Diethyltryptamine, DET);                                  Dimethyltryptamine (trade or other   name: DMT);                                  5-methoxy-N, N-diisopropyltryptamine   (5-MeO-DiPT);                                  O-Acetylpsilocin (Trade or other name:   4-Aco-DMT);                                  Psilocin; and                                  Psilocybin;                (6)  2,5-Dimethoxyphenethylamine and any compound   structurally derived from 2,5-Dimethoxyphenethylamine by   substitution at the 4-position of the phenyl ring to any extent   (including alkyl, alkoxy, alkylenedioxy, haloalkyl, or halide   substituents), including, by example, compounds such as:                      4-Bromo-2,5-dimethoxyphenethylamine (trade or   other name: 2C-B);                      4-Chloro-2,5-dimethoxyphenethylamine (trade or   other name: 2C-C);                      2,5-Dimethoxy-4-methylphenethylamine (trade or   other name: 2C-D);                      4-Ethyl-2,5-dimethoxyphenethylamine (trade or   other name: 2C-E);                      4-Iodo-2,5-dimethoxyphenethylamine (trade or   other name: 2C-I);                      2,5-Dimethoxy-4-nitrophenethylamine (trade or   other name: 2C-N);                      2,5-Dimethoxy-4-(n)-propylphenethylamine (trade   or other name: 2C-P);                      4-Ethylthio-2,5-dimethoxyphenethylamine (trade   or other name: 2C-T-2);                      4-Isopropylthio-2,5-dimethoxyphenethylamine   (trade or other name: 2C-T-4); and                      2,5-Dimethoxy-4-(n)-propylthiophenethylamine   (trade or other name:  2C-T-7); and                (7)  2,5-Dimethoxyamphetamine and any compound   structurally derived from 2,5-Dimethoxyamphetamine by substitution   at the 4-position of the phenyl ring to any extent (including alkyl,   alkoxy, alkylenedioxy, haloalkyl, or halide substituents),   including, by example, compounds such as:                      4-Ethylthio-2,5-dimethoxyamphetamine (trade or   other name: Aleph-2);                      4-Isopropylthio-2,5-dimethoxyamphetamine (trade   or other name: Aleph-4);                      4-Bromo-2,5-dimethoxyamphetamine (trade or other   name: DOB);                      4-Chloro-2,5-dimethoxyamphetamine (trade or   other name: DOC);                      2,5-Dimethoxy-4-ethylamphetamine (trade or other   name: DOET);                      4-Iodo-2,5-dimethoxyamphetamine (trade or other   name: DOI);                      2,5-Dimethoxy-4-methylamphetamine (trade or   other name: DOM);                      2,5-Dimethoxy-4-nitroamphetamine (trade or other   name: DON);                      4-Isopropyl-2,5-dimethoxyamphetamine (trade or   other name: DOIP); and                      2,5-Dimethoxy-4-(n)-propylamphetamine (trade or   other name: DOPR).          SECTION 8.  Subchapter D, Chapter 481, Health and Safety   Code, is amended by adding Section 481.1032 to read as follows:          Sec. 481.1032.  PENALTY GROUP 2-B. (a) Penalty Group 2-B   consists of any quantity of the following substances, their salts,   isomers, and salts of isomers, unless specifically excepted, if the   existence of these salts, isomers, and salts of isomers is possible   within the specific chemical designation:                Tetrahydrocannabinols, other than marihuana, and   synthetic equivalents of the substances contained in the plant, or   in the resinous extractives of Cannabis, or synthetic substances,   derivatives, and their isomers with similar chemical structure and   pharmacological activity such as:                      delta-1 cis or trans tetrahydrocannabinol, and   their optical isomers;                      delta-6 cis or trans tetrahydrocannabinol, and   their optical isomers;                      delta-3, 4 cis or trans tetrahydrocannabinol, and   their optical isomers; or                      compounds of these structures, regardless of   numerical designation of atomic positions, since nomenclature of   these substances is not internationally standardized.          (b)  For the purposes of this section, the term "isomer"   includes an optical, position, or geometric isomer.          SECTION 9.  Section 481.106, Health and Safety Code, is   amended to read as follows:          Sec. 481.106.  CLASSIFICATION OF CONTROLLED SUBSTANCE   ANALOGUE. For the purposes of the prosecution of an offense under   this subchapter involving the manufacture, delivery, or possession   of a controlled substance, Penalty Groups 1, 1-A, 1-B, 2, [and] 2-A,   and 2-B include a controlled substance analogue that:                (1)  has a chemical structure substantially similar to   the chemical structure of a controlled substance listed in the   applicable penalty group; or                (2)  is specifically designed to produce an effect   substantially similar to, or greater than, a controlled substance   listed in the applicable penalty group.          SECTION 10.  The heading to Section 481.113, Health and   Safety Code, is amended to read as follows:          Sec. 481.113.  OFFENSE: MANUFACTURE OR DELIVERY OF SUBSTANCE   IN PENALTY GROUP 2, [OR] 2-A, OR 2-B.          SECTION 11.  Section 481.113(a), Health and Safety Code, is   amended to read as follows:          (a)  Except as authorized by this chapter, a person commits   an offense if the person knowingly manufactures, delivers, or   possesses with intent to deliver a controlled substance listed in   Penalty Group 2, [or] 2-A, or 2-B.          SECTION 12.  Section 481.115(h), Health and Safety Code, is   amended to read as follows:          (h)  The defense to prosecution provided by Subsection (g) is   not available if:                (1)  at the time the request for emergency medical   assistance was made:                      (A)  a peace officer was in the process of   arresting the actor or executing a search warrant describing the   actor or the place from which the request for medical assistance was   made; or                      (B)  the actor is committing another offense,   other than an offense punishable under Section 481.1151(b)(1),   481.116(b), 481.1161(b)(1), (1-a), or (2), 481.117(b), 481.118(b),   or 481.121(b)(1), (1-a), or (2), or an offense under Section   481.119(b), 481.125(a), 483.041(a), or 485.031(a);                (2)  the actor has been previously convicted of or   placed on deferred adjudication community supervision for an   offense under this chapter or Chapter 483 or 485;                (3)  the actor was acquitted in a previous proceeding   in which the actor successfully established the defense under that   subsection or Section 481.1151(c), 481.116(f), 481.1161(c),   481.117(f), 481.118(f), 481.119(c), 481.121(c), 481.125(g),   483.041(e), or 485.031(c); or                (4)  at any time during the 18-month period preceding   the date of the commission of the instant offense, the actor   requested emergency medical assistance in response to the possible   overdose of the actor or another person.          SECTION 13.  Section 481.1151(d), Health and Safety Code, is   amended to read as follows:          (d)  The defense to prosecution provided by Subsection (c) is   not available if:                (1)  at the time the request for emergency medical   assistance was made:                      (A)  a peace officer was in the process of   arresting the actor or executing a search warrant describing the   actor or the place from which the request for medical assistance was   made; or                      (B)  the actor is committing another offense,   other than an offense punishable under Section 481.115(b),   481.116(b), 481.1161(b)(1), (1-a), or (2), 481.117(b), 481.118(b),   or 481.121(b)(1), (1-a), or (2), or an offense under Section   481.119(b), 481.125(a), 483.041(a), or 485.031(a);                (2)  the actor has been previously convicted of or   placed on deferred adjudication community supervision for an   offense under this chapter or Chapter 483 or 485;                (3)  the actor was acquitted in a previous proceeding   in which the actor successfully established the defense under that   subsection or Section 481.115(g), 481.116(f), 481.1161(c),   481.117(f), 481.118(f), 481.119(c), 481.121(c), 481.125(g),   483.041(e), or 485.031(c); or                (4)  at any time during the 18-month period preceding   the date of the commission of the instant offense, the actor   requested emergency medical assistance in response to   the  possible overdose of the actor or another person.          SECTION 14.  Section 481.116(g), Health and Safety Code, is   amended to read as follows:          (g)  The defense to prosecution provided by Subsection (f) is   not available if:                (1)  at the time the request for emergency medical   assistance was made:                      (A)  a peace officer was in the process of   arresting the actor or executing a search warrant describing the   actor or the place from which the request for medical assistance was   made; or                      (B)  the actor is committing another offense,   other than an offense punishable under Section 481.115(b),   481.1151(b)(1), 481.1161(b)(1), (1-a), or (2), 481.117(b),   481.118(b), or 481.121(b)(1), (1-a), or (2), or an offense under   Section 481.119(b), 481.125(a), 483.041(a), or 485.031(a);                (2)  the actor has been previously convicted of or   placed on deferred adjudication community supervision for an   offense under this chapter or Chapter 483 or 485;                (3)  the actor was acquitted in a previous proceeding   in which the actor successfully established the defense under that   subsection or Section 481.115(g), 481.1151(c), 481.1161(c),   481.117(f), 481.118(f), 481.119(c), 481.121(c), 481.125(g),   483.041(e), or 485.031(c); or                (4)  at any time during the 18-month period preceding   the date of the commission of the instant offense, the actor   requested emergency medical assistance in response to   the  possible overdose of the actor or another person.          SECTION 15.  The heading to Section 481.1161, Health and   Safety Code, is amended to read as follows:          Sec. 481.1161.  OFFENSE: POSSESSION OF SUBSTANCE IN PENALTY   GROUP 2-A OR 2-B.          SECTION 16.  Sections 481.1161(a), (b), (c), and (d), Health   and Safety Code, are amended to read as follows:          (a)  Except as authorized by this chapter, a person commits   an offense if the person knowingly possesses a controlled substance   listed in Penalty Group 2-A or 2-B, unless the person obtained the   substance directly from or under a valid prescription or order of a   practitioner acting in the course of professional practice.          (b)  An offense under this section is:                (1)  a Class C misdemeanor if the amount of the   controlled substance possessed is, by aggregate weight, including   adulterants or dilutants, one ounce or less;                (1-a)  a Class B misdemeanor if the amount of the   controlled substance possessed is, by aggregate weight, including   adulterants or dilutants, two ounces or less but more than one   ounce;                (2)  a Class A misdemeanor if the amount of the   controlled substance possessed is, by aggregate weight, including   adulterants or dilutants, four ounces or less but more than two   ounces;                (3)  a state jail felony if the amount of the controlled   substance possessed is, by aggregate weight, including adulterants   or dilutants, five pounds or less but more than four ounces;                (4)  a felony of the third degree if the amount of the   controlled substance possessed is, by aggregate weight, including   adulterants or dilutants, 50 pounds or less but more than 5 pounds;                (5)  a felony of the second degree if the amount of the   controlled substance possessed is, by aggregate weight, including   adulterants or dilutants, 2,000 pounds or less but more than 50   pounds; and                (6)  a felony of the first degree punishable by   imprisonment in the Texas Department of Criminal Justice for life   or for a term of not more than 99 years or less than 5 years, and a   fine not to exceed $50,000, if the amount of the controlled   substance possessed is, by aggregate weight, including adulterants   or dilutants, more than 2,000 pounds.          (c)  It is a defense to prosecution for an offense punishable   under Subsection (b)(1), (1-a), or (2) that the actor:                (1)  was the first person to request emergency medical   assistance in response to the possible overdose of another person   and:                      (A)  made the request for medical assistance   during an ongoing medical emergency;                      (B)  remained on the scene until the medical   assistance arrived; and                      (C)  cooperated with medical assistance and law   enforcement personnel; or                (2)  was the victim of a possible overdose for which   emergency medical assistance was requested, by the actor or by   another person, during an ongoing medical emergency.          (d)  The defense to prosecution provided by Subsection (c) is   not available if:                (1)  at the time the request for emergency medical   assistance was made:                      (A)  a peace officer was in the process of   arresting the actor or executing a search warrant describing the   actor or the place from which the request for medical assistance was   made; or                      (B)  the actor is committing another offense,   other than an offense punishable under Section 481.115(b),   481.1151(b)(1), 481.116(b), 481.117(b), 481.118(b), or   481.121(b)(1), (1-a), or (2), or an offense under Section   481.119(b), 481.125(a), 483.041(a), or 485.031(a);                (2)  the actor has been previously convicted of or   placed on deferred adjudication community supervision for an   offense under this chapter or Chapter 483 or 485;                (3)  the actor was acquitted in a previous proceeding   in which the actor successfully established the defense under that   subsection or Section 481.115(g), 481.1151(c), 481.116(f),   481.117(f), 481.118(f), 481.119(c), 481.121(c), 481.125(g),   483.041(e), or 485.031(c); or                (4)  at any time during  the 18-month period preceding   the date of the commission of the instant offense, the actor   requested emergency medical assistance in response to   the  possible overdose of the actor or another person.          SECTION 17.  Section 481.117(g), Health and Safety Code, is   amended to read as follows:          (g)  The defense to prosecution provided by Subsection (f) is   not available if:                (1)  at the time the request for emergency medical   assistance was made:                      (A)  a peace officer was in the process of   arresting the actor or executing a search warrant describing the   actor or the place from which the request for medical assistance was   made; or                      (B)  the actor is committing another offense,   other than an offense punishable under Section 481.115(b),   481.1151(b)(1), 481.116(b), 481.1161(b)(1), (1-a), or (2),   481.118(b), or 481.121(b)(1), (1-a), or (2), or an offense under   Section 481.119(b), 481.125(a), 483.041(a), or 485.031(a);                (2)  the actor has been previously convicted of or   placed on deferred adjudication community supervision for an   offense under this chapter or Chapter 483 or 485;                (3)  the actor was acquitted in a previous proceeding   in which the actor successfully established the defense under that   subsection or Section 481.115(g), 481.1151(c), 481.116(f),   481.1161(c), 481.118(f), 481.119(c), 481.121(c), 481.125(g),   483.041(e), or 485.031(c); or                (4)  at any time during the 18-month period preceding   the date of the commission of the instant offense, the actor   requested emergency medical assistance in response to   the  possible overdose of the actor or another person.          SECTION 18.  Section 481.118(g), Health and Safety Code, is   amended to read as follows:          (g)  The defense to prosecution provided by Subsection (f) is   not available if:                (1)  at the time the request for emergency medical   assistance was made:                      (A)  a peace officer was in the process of   arresting the actor or executing a search warrant describing the   actor or the place from which the request for medical assistance was   made; or                      (B)  the actor is committing another offense,   other than an offense punishable under Section 481.115(b),   481.1151(b)(1), 481.116(b), 481.1161(b)(1), (1-a), or (2),   481.117(b), or 481.121(b)(1), (1-a), or (2), or an offense under   Section 481.119(b), 481.125(a), 483.041(a), or 485.031(a);                (2)  the actor has been previously convicted of or   placed on deferred adjudication community supervision for an   offense under this chapter or Chapter 483 or 485;                (3)  the actor was acquitted in a previous proceeding   in which the actor successfully established the defense under that   subsection or Section 481.115(g), 481.1151(c), 481.116(f),   481.1161(c), 481.117(f), 481.119(c), 481.121(c), 481.125(g),   483.041(e), or 485.031(c); or                (4)  at any time during the 18-month period preceding   the date of the commission of the instant offense, the actor   requested emergency medical assistance in response to   the  possible overdose of the actor or another person.          SECTION 19.  Section 481.119(d), Health and Safety Code, is   amended to read as follows:          (d)  The defense to prosecution provided by Subsection (c) is   not available if:                (1)  at the time the request for emergency medical   assistance was made:                      (A)  a peace officer was in the process of   arresting the actor or executing a search warrant describing the   actor or the place from which the request for medical assistance was   made; or                      (B)  the actor is committing another offense,   other than an offense punishable under Section 481.115(b),   481.1151(b)(1), 481.116(b), 481.1161(b)(1), (1-a), or (2),   481.117(b), 481.118(b), or 481.121(b)(1), (1-a), or (2), or an   offense under Section 481.125(a), 483.041(a), or 485.031(a);                (2)  the actor has been previously convicted of or   placed on deferred adjudication community supervision for an   offense under this chapter or Chapter 483 or 485;                (3)  the actor was acquitted in a previous proceeding   in which the actor successfully established the defense under that   subsection or Section 481.115(g), 481.1151(c), 481.116(f),   481.1161(c), 481.117(f), 481.118(f), 481.121(c), 481.125(g),   483.041(e), or 485.031(c); or                (4)  at any time during the 18-month period preceding   the date of the commission of the instant offense, the actor   requested emergency medical assistance in response to   the  possible overdose of the actor or another person.          SECTION 20.  Sections 481.121(b), (c), and (d), Health and   Safety Code, are amended to read as follows:          (b)  An offense under Subsection (a) is:                (1)  a Class C misdemeanor if the amount of marihuana   possessed is one ounce or less;                (1-a)  a Class B misdemeanor if the amount of marihuana   possessed is two ounces or less but more than one ounce;                (2)  a Class A misdemeanor if the amount of marihuana   possessed is four ounces or less but more than two ounces;                (3)  a state jail felony if the amount of marihuana   possessed is five pounds or less but more than four ounces;                (4)  a felony of the third degree if the amount of   marihuana possessed is 50 pounds or less but more than 5 pounds;                (5)  a felony of the second degree if the amount of   marihuana possessed is 2,000 pounds or less but more than 50 pounds;   and                (6)  a felony of the first degree punishable by   imprisonment in the Texas Department of Criminal Justice for life   or for a term of not more than 99 years or less than 5 years, and a   fine not to exceed $50,000, if the amount of marihuana possessed is   more than 2,000 pounds.          (c)  It is a defense to prosecution for an offense punishable   under Subsection (b)(1), (1-a), or (2) that the actor:                (1)  was the first person to request emergency medical   assistance in response to the possible overdose of another person   and:                      (A)  made the request for medical assistance   during an ongoing medical emergency;                      (B)  remained on the scene until the medical   assistance arrived; and                      (C)  cooperated with medical assistance and law   enforcement personnel; or                (2)  was the victim of a possible overdose for which   emergency medical assistance was requested, by the actor or by   another person, during an ongoing medical emergency.          (d)  The defense to prosecution provided by Subsection (c) is   not available if:                (1)  at the time the request for emergency medical   assistance was made:                      (A)  a peace officer was in the process of   arresting the actor or executing a search warrant describing the   actor or the place from which the request for medical assistance was   made; or                      (B)  the actor is committing another offense,   other than an offense punishable under Section 481.115(b),   481.1151(b)(1), 481.116(b), 481.1161(b)(1), (1-a), or (2),   481.117(b), or 481.118(b), or an offense under Section 481.119(b),   481.125(a), 483.041(a), or 485.031(a);                (2)  the actor has been previously convicted of or   placed on deferred adjudication community supervision for an   offense under this chapter or Chapter 483 or 485;                (3)  the actor was acquitted in a previous proceeding   in which the actor successfully established the defense under that   subsection or Section 481.115(g), 481.1151(c), 481.116(f),   481.1161(c), 481.117(f), 481.118(f), 481.119(c), 481.125(g),   483.041(e), or 485.031(c); or                (4)  at any time during the 18-month period preceding   the date of the commission of the instant offense, the actor   requested emergency medical assistance in response to the possible   overdose of the actor or another person.          SECTION 21.  Section 481.122(a), Health and Safety Code, is   amended to read as follows:          (a)  A person commits an offense if the person knowingly   delivers a controlled substance listed in Penalty Group 1, 1-A,   1-B, 2, 2-A, 2-B, or 3 or knowingly delivers marihuana and the   person delivers the controlled substance or marihuana to a person:                (1)  who is a child;                (2)  who is enrolled in a public or private primary or   secondary school; or                (3)  who the actor knows or believes intends to deliver   the controlled substance or marihuana to a person described by   Subdivision (1) or (2).          SECTION 22.  Section 481.124(d), Health and Safety Code, is   amended to read as follows:          (d)  An offense under this section is:                (1)  a felony of the second degree if the controlled   substance is listed in Penalty Group 1, 1-A, or 1-B;                (2)  a felony of the third degree if the controlled   substance is listed in Penalty Group 2, 2-A, or 2-B;                (3)  a state jail felony if the controlled substance is   listed in Penalty Group 3 or 4; or                (4)  a Class A misdemeanor if the controlled substance   is listed in a schedule by an action of the commissioner under this   chapter but not listed in a penalty group.          SECTION 23.  Section 481.125(h), Health and Safety Code, is   amended to read as follows:          (h)  The defense to prosecution provided by Subsection (g) is   not available if:                (1)  at the time the request for emergency medical   assistance was made:                      (A)  a peace officer was in the process of   arresting the actor or executing a search warrant describing the   actor or the place from which the request for medical assistance was   made; or                      (B)  the actor is committing another offense,   other than an offense punishable under Section 481.115(b),   481.1151(b)(1), 481.116(b), 481.1161(b)(1), (1-a), or (2),   481.117(b), 481.118(b), or 481.121(b)(1), (1-a), or (2), or an   offense under Section 481.119(b), 483.041(a), or 485.031(a);                (2)  the actor has been previously convicted of or   placed on deferred adjudication community supervision for an   offense under this chapter or Chapter 483 or 485;                (3)  the actor was acquitted in a previous proceeding   in which the actor successfully established the defense under that   subsection or Section 481.115(g), 481.1151(c), 481.116(f),   481.1161(c), 481.117(f), 481.118(f), 481.119(c), 481.121(c),   483.041(e), or 485.031(c); or                (4)  at any time during the 18-month period preceding   the date of the commission of the instant offense, the actor   requested emergency medical assistance in response to the possible   overdose of the actor or another person.          SECTION 24.  Section 481.134(f), Health and Safety Code, is   amended to read as follows:          (f)  An offense otherwise punishable under Section   481.1161(b)(1-a), 481.118(b), 481.119(b), 481.120(b)(1), or   481.121(b)(1-a) [481.121(b)(1)] is a Class A misdemeanor if it is   shown on the trial of the offense that the offense was committed:                (1)  in, on, or within 1,000 feet of any real property   that is owned, rented, or leased to a school or school board, the   premises of a public or private youth center, or a playground;                (2)  on a school bus; or                (3)  by any unauthorized person 18 years of age or   older, in, on, or within 1,000 feet of premises owned, rented, or   leased by a general residential operation operating as a   residential treatment center.          SECTION 25.  Section 483.041(f), Health and Safety Code, is   amended to read as follows:          (f)  The defense to prosecution provided by Subsection (e) is   not available if:                (1)  at the time the request for emergency medical   assistance was made:                      (A)  a peace officer was in the process of   arresting the actor or executing a search warrant describing the   actor or the place from which the request for medical assistance was   made; or                      (B)  the actor is committing another offense,   other than an offense punishable under Section 481.115(b),   481.1151(b)(1), 481.116(b), 481.1161(b)(1), (1-a), or (2),   481.117(b), 481.118(b), or 481.121(b)(1), (1-a), or (2), or an   offense under Section 481.119(b), 481.125(a), or 485.031(a);                (2)  the actor has been previously convicted of or   placed on deferred adjudication community supervision for an   offense under this chapter or Chapter 481 or 485;                (3)  the actor was acquitted in a previous proceeding   in which the actor successfully established the defense under that   subsection or Section 481.115(g), 481.1151(c), 481.116(f),   481.1161(c), 481.117(f), 481.118(f), 481.119(c), 481.121(c),   481.125(g), or 485.031(c); or                (4)  at any time during the 18-month period preceding   the date of the commission of the instant offense, the actor   requested emergency medical assistance in response to the possible   overdose of the actor or another person.          SECTION 26.  Section 485.031(d), Health and Safety Code, is   amended to read as follows:          (d)  The defense to prosecution provided by Subsection (c) is   not available if:                (1)  at the time the request for emergency medical   assistance was made:                      (A)  a peace officer was in the process of   arresting the actor or executing a search warrant describing the   actor or the place from which the request for medical assistance was   made; or                      (B)  the actor is committing another offense,   other than an offense punishable under Section 481.115(b),   481.1151(b)(1), 481.116(b), 481.1161(b)(1), (1-a), or (2),   481.117(b), 481.118(b), or 481.121(b)(1), (1-a), or (2), or an   offense under Section 481.119(b), 481.125(a), or 483.041(a);                (2)  the actor has been previously convicted of or   placed on deferred adjudication community supervision for an   offense under this chapter or Chapter 481 or 483;                (3)  the actor was acquitted in a previous proceeding   in which the actor successfully established the defense under that   subsection or Section 481.115(g), 481.1151(c), 481.116(f),   481.1161(c), 481.117(f), 481.118(f), 481.119(c), 481.121(c),   481.125(g), or 483.041(e); or                (4)  at any time during the 18-month period preceding   the date of the commission of the instant offense, the actor   requested emergency medical assistance in response to the possible   overdose of the actor or another person.          SECTION 27.  Sections 551.003(11) and (12), Occupations   Code, are amended to read as follows:                (11)  "Controlled substance" means a substance,   including a drug:                      (A)  listed in Schedule I, II, III, IV, or V, as   established by the commissioner of public health under Chapter 481,   Health and Safety Code, or in Penalty Group 1, 1-A, 1-B, 2, 2-A,   2-B, 3, or 4, Chapter 481; or                      (B)  included in Schedule I, II, III, IV, or V of   the Comprehensive Drug Abuse Prevention and Control Act of 1970 (21   U.S.C. Section 801 et seq.).                (12)  "Dangerous drug" means a drug or device that:                      (A)  is not included in Penalty Group 1, 1-B, 2,   2-A, 2-B, 3, or 4, Chapter 481, Health and Safety Code, and is   unsafe for self-medication; or                      (B)  bears or is required to bear the legend:                            (i)  "Caution: federal law prohibits   dispensing without prescription" or "Rx only" or another legend   that complies with federal law; or                            (ii)  "Caution: federal law restricts this   drug to use by or on the order of a licensed veterinarian."          SECTION 28.  Section 521.371(3), Transportation Code, is   amended to read as follows:                (3)  "Drug offense" has the meaning assigned under 23   U.S.C. Section 159(c) and includes an offense under Section 49.04,   49.07, or 49.08, Penal Code, that is committed as a result of the   introduction into the body of any substance the possession of which   is prohibited under the Controlled Substances Act. The term does   not include an offense punishable by fine only under the laws of   this state.          SECTION 29.  The changes in law made by this Act apply only   to an offense committed on or after the effective date of this Act.   An offense committed before the effective date of this Act is   governed by the law in effect on the date the offense was committed,   and the former law is continued in effect for that purpose. For   purposes of this section, an offense was committed before the   effective date of this Act if any element of the offense was   committed before that date.          SECTION 30.  This Act takes effect September 1, 2025.